InvestorsHub Logo
Followers 12
Posts 1019
Boards Moderated 0
Alias Born 03/24/2013

Re: funindasun post# 18666

Thursday, 07/19/2018 12:06:04 AM

Thursday, July 19, 2018 12:06:04 AM

Post# of 20689
Sandoz and Momenta together netted some ~200m in revenues from gCopaxone 20mg alone. 40 mg yet to kick in.

Is it fair to value momenta's gHumira at $100m?

I think it's easily worth $500m+. The $50m patent dance may not be required now in light of MYL settlement.